C3.ai, Inc. (NYSE:AI – Get Rating) has received an average rating of “Hold” from the twelve analysts that are currently covering the firm, MarketBeat reports. Four research analysts have rated the stock with a sell rating, five have issued a hold rating and three have assigned a buy rating to the company. The average 12 month target price among brokers that have covered the stock in the last year is $27.89.
AI has been the subject of several analyst reports. Canaccord Genuity Group reduced their price objective on C3.ai from $34.00 to $23.00 and set a “hold” rating for the company in a research note on Thursday, March 3rd. JMP Securities reduced their price objective on C3.ai from $96.00 to $59.00 and set a “market outperform” rating for the company in a research note on Thursday, March 3rd. Zacks Investment Research downgraded C3.ai from a “buy” rating to a “hold” rating in a research note on Tuesday, May 3rd. Morgan Stanley reduced their price objective on C3.ai from $31.00 to $20.00 and set an “underweight” rating for the company in a research note on Friday, March 25th. Finally, Deutsche Bank Aktiengesellschaft downgraded C3.ai from a “hold” rating to a “sell” rating and reduced their price objective for the company from $36.00 to $18.00 in a research note on Friday, March 4th.
AI opened at $17.15 on Thursday. C3.ai has a 12 month low of $13.37 and a 12 month high of $76.85. The stock has a market capitalization of $1.82 billion, a price-to-earnings ratio of -11.06 and a beta of 0.69. The business has a fifty day moving average price of $19.47 and a 200 day moving average price of $27.12.
In related news, CFO Juho Parkkinen sold 4,253 shares of the company’s stock in a transaction that occurred on Monday, March 21st. The stock was sold at an average price of $21.58, for a total value of $91,779.74. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In the last 90 days, insiders sold 10,816 shares of company stock worth $218,278. Insiders own 52.65% of the company’s stock.
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Quantamental Technologies LLC grew its holdings in C3.ai by 52.7% during the 1st quarter. Quantamental Technologies LLC now owns 19,037 shares of the company’s stock valued at $432,000 after buying an additional 6,574 shares during the last quarter. Delphia USA Inc. acquired a new stake in C3.ai during the 1st quarter valued at $220,000. Geneos Wealth Management Inc. grew its holdings in C3.ai by 10.6% during the 1st quarter. Geneos Wealth Management Inc. now owns 23,842 shares of the company’s stock valued at $541,000 after buying an additional 2,288 shares during the last quarter. PDT Partners LLC acquired a new stake in C3.ai during the 1st quarter valued at $3,119,000. Finally, Captrust Financial Advisors grew its holdings in C3.ai by 15.3% during the 1st quarter. Captrust Financial Advisors now owns 8,897 shares of the company’s stock valued at $202,000 after buying an additional 1,180 shares during the last quarter. Institutional investors and hedge funds own 45.41% of the company’s stock.
C3.ai Company Profile (Get Rating)
C3.ai, Inc operates as an enterprise artificial intelligence (AI) software company. The company provides software-as-a-service applications for enterprises. Its software solutions include C3 AI Suite, a platform-as-a-service application development and runtime environment that enables customers to design, develop, and deploy enterprise AI applications; and C3 AI Applications, which include industry-specific and application-specific turnkey AI solutions.
- Get a free copy of the StockNews.com research report on C3.ai (AI)
- Simply Good Foods Stock is Simply Looking Good Down Here
- Shoe Carnival’s Q1 Results Are No Joke, Shares Fall 15%
- Analog Devices Is Ready To Scale New Highs Despite Tech Wreck
- Dynatrace: Fundamentals are Positive While Being Punished
- Now’s The Time To Buy Disney (NYSE: DIS)
Receive News & Ratings for C3.ai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for C3.ai and related companies with MarketBeat.com's FREE daily email newsletter.